Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Hydrix Limited ( (AU:HYD) ) is now available.
Hydrix Limited announced a positive trading update for the June quarter, highlighting increased sales activity and recent contract wins that support near-term growth. The company reported $2.4 million in quarterly revenues, with significant contributions from cardiac and medtech products and emerging growth from defense clients. Hydrix secured 18 new and existing client contracts totaling $3.5 million in revenues and has 20 active clients with a potential future project revenue base of $40 million. Despite a $0.76 million operating loss, this marks a 45% improvement from the previous corresponding period, indicating a positive trend and potential for further revenue momentum in the coming months.
More about Hydrix Limited
Hydrix Limited is a product innovation company focused on enhancing health, safety, and well-being. It operates in three segments: Services, which designs and delivers innovative products; Ventures, which invests in promising medtech clients; and Medical, which distributes disruptive cardiovascular products.
Average Trading Volume: 156,339
Technical Sentiment Signal: Hold
Current Market Cap: A$4.09M
Learn more about HYD stock on TipRanks’ Stock Analysis page.